Business Description
Seaport Therapeutics Inc
NAICS : 541715
SIC : 2834
ISIN : US81221K1088
Description
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 42.51 | |||||
Equity-to-Asset | -0.37 | |||||
Debt-to-Equity | -0.06 | |||||
Debt-to-EBITDA | -0.06 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 86.5 | |||||
9-Day RSI | 75.02 | |||||
14-Day RSI | 65.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 17.46 | |||||
Quick Ratio | 17.46 | |||||
Cash Ratio | 16.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -26.52 | |||||
ROIC % | -415.64 | |||||
ROC (Joel Greenblatt) % | -1679.38 | |||||
ROCE % | -32.28 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -11.11 | |||||
EV-to-EBITDA | -11.29 | |||||
EV-to-FCF | -12.39 | |||||
Earnings Yield (Greenblatt) % | -9 | |||||
FCF Yield % | -6.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SPTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Seaport Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.94 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 65.94 | ||
| 14-Day ATR ($) | 1.426915 | ||
| 20-Day SMA ($) | 17.925 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 14.85 - 23 | ||
| Shares Outstanding (Mil) | 53.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Seaport Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Seaport Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Seaport Therapeutics Inc Frequently Asked Questions
What is Seaport Therapeutics Inc(SPTX)'s stock price today?
The current price of SPTX is $21.43. The 52 week high of SPTX is $23.00 and 52 week low is $14.85.
When is next earnings date of Seaport Therapeutics Inc(SPTX)?
The next earnings date of Seaport Therapeutics Inc(SPTX) is .
Does Seaport Therapeutics Inc(SPTX) pay dividends? If so, how much?
Seaport Therapeutics Inc(SPTX) does not pay dividend.
Guru Commentaries on NAS:SPTX
No articles.
Press Release
Articles on Seaport Therapeutics Inc
No articles.
Headlines
See More- 1
Jun 08, 2026
Seaport Therapeutics, Inc. GAAP EPS of -$10.34
Seeking Alpha • 7:11am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers